These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24761872)

  • 1. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.
    Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC
    Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elevated Fas expression is related to increased apoptosis of circulating CD8(+)T cell in patients with hepatocellular carcinoma].
    Guo CL; Bi YM; Liu Z; Xu Y; Sun YX; Wang QC
    Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):125-129. PubMed ID: 29804379
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma Level of Interleukin-35 as an Independent Prognostic Indicator in Hepatocellular Carcinoma.
    Qiu X; Wang X; Song Y; Chen L
    Dig Dis Sci; 2016 Dec; 61(12):3513-3521. PubMed ID: 27699510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Fas antigen (CD95) in peripheral blood lymphocytes and in liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma.
    Yuen MF; Hughes RD; Heneghan MA; Langley PG; Norris S
    Cancer; 2001 Oct; 92(8):2136-41. PubMed ID: 11596030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH
    Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
    Fukuzawa Y; Takahashi K; Furuta K; Tagaya T; Ishikawa T; Wada K; Omoto Y; Koji T; Kakumu S
    J Gastroenterol; 2001 Oct; 36(10):681-8. PubMed ID: 11686478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequency and FOXP3 expression of human CD8
    Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF
    Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD3
    Ivanova OK; Sharapova TN; Romanova EA; Soshnikova NV; Sashchenko LP; Yashin DV
    J Cell Biochem; 2017 Oct; 118(10):3359-3366. PubMed ID: 28294381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a FOXP3(+)CD3(+)CD56(+) population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma.
    Li X; Peng J; Pang Y; Yu S; Yu X; Chen P; Wang W; Han W; Zhang J; Yin Y; Zhang Y
    Sci Rep; 2015 Oct; 5():14757. PubMed ID: 26437631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancer.
    Yoshikawa T; Saito H; Osaki T; Matsumoto S; Tsujitani S; Ikeguchi M
    J Surg Res; 2008 Aug; 148(2):143-51. PubMed ID: 18561948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct different sensitivity of Treg and Th17 cells to Fas-mediated apoptosis signaling in patients with acute coronary syndrome.
    Li Q; Wang Y; Wang Y; Zhou Q; Chen K; Wang YM; Wei W; Wang Y
    Int J Clin Exp Pathol; 2013; 6(2):297-307. PubMed ID: 23330016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway.
    Tateyama M; Oyaizu N; McCloskey TW; Than S; Pahwa S
    Blood; 2000 Jul; 96(1):195-202. PubMed ID: 10891451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.
    Strauss L; Bergmann C; Whiteside TL
    J Immunol; 2009 Feb; 182(3):1469-80. PubMed ID: 19155494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation.
    Contini P; Ghio M; Merlo A; Poggi A; Indiveri F; Puppo F
    J Immunol; 2005 Dec; 175(11):7244-54. PubMed ID: 16301629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
    Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
    Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship and clinical significance of TGF-beta1 expression with Treg cell infiltration in hepatocellular carcinoma.
    Lin GH; Wang J; Li SH; Wang J; Xu L; Li SP
    Chin J Cancer; 2010 Apr; 29(4):403-7. PubMed ID: 20346216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective depletion of FOXP3(high) cells by Fas-Fas-L-induced apoptosis occurs in CD4(+)CD25(+)-enriched populations during repeated expansion.
    Zhang W; Nair S; Danby R; Peniket A; Roberts DJ
    Cytotherapy; 2013 Oct; 15(10):1286-96. PubMed ID: 23993302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.